PERRELLI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 848
EU - Europa 438
AS - Asia 171
OC - Oceania 2
SA - Sud America 1
Totale 1460
Nazione #
US - Stati Uniti d'America 844
IT - Italia 185
CN - Cina 111
IE - Irlanda 80
SE - Svezia 62
UA - Ucraina 36
VN - Vietnam 27
FR - Francia 15
GB - Regno Unito 15
PL - Polonia 14
KR - Corea 9
BE - Belgio 8
HK - Hong Kong 7
JP - Giappone 7
DE - Germania 6
TW - Taiwan 5
CA - Canada 4
IN - India 4
DK - Danimarca 3
NL - Olanda 3
ES - Italia 2
RO - Romania 2
AT - Austria 1
AU - Australia 1
BY - Bielorussia 1
EC - Ecuador 1
FI - Finlandia 1
LV - Lettonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RU - Federazione Russa 1
SG - Singapore 1
Totale 1460
Città #
Chandler 202
Fairfield 100
Torino 94
Dublin 80
Woodbridge 57
Ashburn 52
Beijing 48
Houston 41
Seattle 39
Jacksonville 36
Wilmington 33
Cambridge 31
Nyköping 30
Pisa 24
Ann Arbor 23
Medford 20
Princeton 15
Warsaw 12
Dong Ket 11
Xian 11
Boston 10
Fremont 10
San Mateo 10
Dearborn 9
Nanjing 9
Brussels 7
Hangzhou 7
Seoul 7
Shanghai 7
Central District 6
Milan 5
Norwalk 5
Redwood City 5
Villeurbanne 5
Aosta 4
San Diego 4
Taipei 4
Copenhagen 3
Kunming 3
Toronto 3
Turin 3
Baotou 2
Bromsgrove 2
Chieri 2
Cuneo 2
Feltre 2
Genova 2
Greifswald 2
Guangzhou 2
Hebei 2
Hefei 2
Jinan 2
Mountain View 2
Phoenix 2
Rochester 2
Rome 2
Santiago De Compostela 2
Silver Spring 2
Tokyo 2
White Lake 2
Auckland 1
Birmingham 1
Cardiff 1
Changsha 1
Chengdu 1
Chicago 1
Edinburgh 1
Falls Church 1
Göttingen 1
Ithaca 1
Kwangju 1
Los Angeles 1
Maastricht 1
Meta 1
Moncalieri 1
Mumbai 1
Napoli 1
New York 1
Oslo 1
Porto 1
Quito 1
Riga 1
Saint Paul 1
Salt Lake City 1
San Francisco 1
Santa Ana Heights 1
Shaan 1
Taizhou 1
Taramani 1
Tianjin 1
Valenza 1
Vienna 1
Wuhan 1
Zevenhuizen 1
Ürümqi 1
Totale 1158
Nome #
KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease 178
Data in support of sustained upregulation of adaptive redox homeostasis mechanisms caused by KRIT1 loss-of-function 127
Yeast-derived recombinant avenanthramides inhibit proliferation, migration and epithelial mesenchymal transition of colon cancer cells 107
Biological activities, health benefits, and therapeutic properties of avenanthramides: From skin protection to prevention and treatment of cerebrovascular diseases 106
Multifunctional Platinum@BSA-Rapamycin Nanocarriers for the Combinatorial Therapy of Cerebral Cavernous Malformation 92
KRIT1 Deficiency Promotes Aortic Endothelial Dysfunction 92
KRIT1 Loss-Of-Function Associated with Cerebral Cavernous Malformation Disease Leads to Enhanced S-Glutathionylation of Distinct Structural and Regulatory Proteins 72
Vitamin D deficiency and the risk of cerebrovascular disease 69
KRIT1 loss of function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: implication for Cerebral Cavernous Malformation disease 65
Altered redox homeostasis and signaling in Cerebral Cavernous Malformation disease: towards a complex but unifying pathogenic mechanism and therapeutic implications 54
Multifunctional platinum@bsa-rapamycin nanocarriers for combinatorial therapy of cerebral cavernous malformation disease 53
Identification of risk factors and biomarkers of diagnostic and prognostic value associated with clinical progression and severity of cerebral cavernous malformations 52
Dicarbonyl stress and s-glutathionylation in cerebrovascular diseases: A focus on cerebral cavernous malformations 50
KRIT1/CCM1 loss-of-function impairs advanced glycation endproducts receptors and detoxification and worsens fructose diet-induced hepatic dysmetabolism 49
Production of KRIT1-knockout and KRIT1-knockin Mouse Embryonic Fibroblasts as Cellular Models of CCM Disease 48
KRIT1 loss-of-function induces a sustained Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: implication for Cerebral Cavernous Malformation disease 48
KRIT1/CCM1 loss-of-function affects sphingolipid metabolism inducing hepatosteatosis and predisposing to liver fibrosis and insulin-resistance 47
Towards precision nanomedicine for cerebrovascular diseases with emphasis on Cerebral Cavernous Malformation (CCM) 46
From Genes and Mechanisms to Molecular-Targeted Therapies: The Long Climb to the Cure of Cerebral Cavernous Malformation (CCM) Disease 42
Protein kinase Cα regulates the nucleocytoplasmic shuttling of KRIT1 38
Fluorescence Analysis of Reactive Oxygen Species (ROS) in Cellular Models of Cerebral Cavernous Malformation Disease 36
Polymorphisms in genes related to oxidative stress and inflammation: Emerging links with the pathogenesis and severity of Cerebral Cavernous Malformation disease 34
Next-Generation Sequencing Advances the Genetic Diagnosis of Cerebral Cavernous Malformation (CCM) 10
Heterozygous Loss of KRIT1 in Mice Affects Metabolic Functions of the Liver, Promoting Hepatic Oxidative and Glycative Stress 4
Distant Recurrence of a Cerebral Cavernous Malformation in the Vicinity of a Developmental Venous Anomaly: Case Report of Local Oxy-Inflammatory Events 1
Totale 1520
Categoria #
all - tutte 2812
article - articoli 0
book - libri 0
conference - conferenze 768
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201825 0000 00 00 12472
2018/2019130 3226 138 321 354420
2019/2020274 148532 1315 3637 47252418
2020/2021377 1932679 2621 1540 43382641
2021/2022345 3021613 298 2424 5239180
2022/2023369 51541873 23114 360 0000
Totale 1520